Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Compston

Showing results (131-140 of 243) with videos related to

Pageof 25
Sort By:
Journal of Neuroimmunology|January 1, 1997
beta-Interferon regulates the immunomodulatory activity of neonatal rodent microgliaG L Hall, M G Wing, D A Compston, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1994
No linkage or association between multiple sclerosis and the myelin basic protein gene in affected sibling pairsN W Wood, P Holmans, D Clayton, et al.
Therapeutic Immunology|August 1, 1995
Ex-vivo whole blood cultures for predicting cytokine-release syndrome: dependence on target antigen and antibody isotypeM G Wing, H Waldmann, J Isaacs, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1995
Genes and susceptibility to multiple sclerosisD A Compston, H Kellar Wood, N Robertson, et al.
Brain : a Journal of Neurology|May 29, 2000
Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK surveyS A Broadley, J Deans, S J Sawcer, et al.
Neurology|November 1, 1986
Cerebrospinal fluid C9 in demyelinating diseaseD A Compston, B P Morgan, D Oleesky, et al.
Neuroreport|February 15, 1995
A proliferative adult human oligodendrocyte progenitorN J Scolding, P J Rayner, J Sussman, et al.
Brain : a Journal of Neurology|January 5, 1999
Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosisN Scolding, R Franklin, S Stevens, et al.
Journal of Neurology|August 1, 1994
Cerebrospinal fluid concentrations of the complement MAC inhibitor CD59 in multiple sclerosis and patients with other neurological disordersJ Roddy, I Clark, B L Hazleman, et al.
European Journal of Human Genetics : EJHG|September 14, 1999
More evidence that founder effects exist in the European populationJ Chataway, S Sawcer, R Feakes, et al.
Pageof 25

Showing results (131-140 of 243) with videos related to

Sort By:
Pageof 25
Journal of Neuroimmunology|January 1, 1997
beta-Interferon regulates the immunomodulatory activity of neonatal rodent microgliaG L Hall, M G Wing, D A Compston, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1994
No linkage or association between multiple sclerosis and the myelin basic protein gene in affected sibling pairsN W Wood, P Holmans, D Clayton, et al.
Therapeutic Immunology|August 1, 1995
Ex-vivo whole blood cultures for predicting cytokine-release syndrome: dependence on target antigen and antibody isotypeM G Wing, H Waldmann, J Isaacs, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1995
Genes and susceptibility to multiple sclerosisD A Compston, H Kellar Wood, N Robertson, et al.
Brain : a Journal of Neurology|May 29, 2000
Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK surveyS A Broadley, J Deans, S J Sawcer, et al.
Neurology|November 1, 1986
Cerebrospinal fluid C9 in demyelinating diseaseD A Compston, B P Morgan, D Oleesky, et al.
Neuroreport|February 15, 1995
A proliferative adult human oligodendrocyte progenitorN J Scolding, P J Rayner, J Sussman, et al.
Brain : a Journal of Neurology|January 5, 1999
Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosisN Scolding, R Franklin, S Stevens, et al.
Journal of Neurology|August 1, 1994
Cerebrospinal fluid concentrations of the complement MAC inhibitor CD59 in multiple sclerosis and patients with other neurological disordersJ Roddy, I Clark, B L Hazleman, et al.
European Journal of Human Genetics : EJHG|September 14, 1999
More evidence that founder effects exist in the European populationJ Chataway, S Sawcer, R Feakes, et al.
Pageof 25